# Repositive

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/repositive

- Industry: Healthcare IT
- Headquarters: Cambridge, UK
- Website: www.repositive.io
- Total disclosed funding: $3.8M
- Latest round: Series A (Feb 1, 2017)
- Investors on record: 6

## About

Repositive Ltd. is a health and wellness information provider specializing in reliable guidance on various health products, including mental health resources and personal care items through comprehensive reviews and comparisons.Founded in 2014 in Cambridge, UK, Repositive Ltd. offers services that empower consumers with trusted health and wellness insights. The company has secured a total of 5 deals, with its most recent funding round occurring on February 1, 2017. During the Series A round, Repositive raised GBP 2.38 million, led by Ananda Impact Ventures, alongside participation from Amadeus Capital Partners and Force Over Mass Capital. The current company valuation stands at GBP 7.10 million post-money.Repositive specializes in delivering high-quality health and wellness information through a variety of services targeted at consumers seeking reliable guidance on various health products. The company provides detailed reviews, comparisons, and insights into trending brands and their offerings, focusing on mental health resources, skincare, hair wellness, and personal care products. Their core offerings include reviews of platforms like BetterHelp, which offers online therapy, as well as product insights related to brands such as Ren Skincare and Nutrafol, which cater to skincare and hair health, respectively. The end users of Repositive’s services include individuals seeking mental health support, skincare enthusiasts, and consumers of feminine hygiene products. Repositive’s insights are accessible across various geographical markets, particularly in North America and Europe, where there is a growing demand for health and wellness information.Repositive's revenue model is primarily based on affiliate partnerships and advertising collaborations with health and wellness brands. By providing comprehensive reviews and comparisons of various health products, the company generates revenue through commissions on sales directed to brand partners, such as those in the mental health and personal care sectors. The transactions often occur through a direct-to-consumer approach, where users access valuable content free of charge while the company earns through referrals or sponsored content. Specific pricing plans for services are not detailed; however, the company may facilitate transactions based on the sales generated through their affiliate links. This structure allows Repositive to maintain a focus on providing unbiased health information while simultaneously driving revenue from its collaborations with established brands in the wellness industry.Repositive Ltd. aims to leverage its recent funding of GBP 2.38 million from the Series A round to enhance its service offerings and expand its presence in the health and wellness sector. The company is currently designing new product lines focused on emerging health trends, with anticipated launch dates in the next 12-18 months. In addition, Repositive plans to target new geographical markets, particularly in Asia and further in Europe, with the goal of establishing a foothold by the end of 2023. The investment received will support these initiatives, facilitating product development and market entry strategies.

## Funding rounds

- Series A, Feb 1, 2017, $3M — Amadeus Capital Partners, Ananda Impact Ventures, Force Over Mass Capital
- Seed, Dec 18, 2015, $0.9M — Amadeus Capital Partners, Cambridge Angels Group, Seedcamp, ClearlySo

## Investors

- Amadeus Capital Partners (https://capitalatlas.ai/funds/amadeus-capital-partners) — Seed, Series A
- Cambridge Angels Group — Seed
- Seedcamp (https://capitalatlas.ai/funds/seedcamp) — Seed
- ClearlySo — Seed
- Ananda Impact Ventures (https://capitalatlas.ai/funds/ananda-impact-ventures) — Series A
- Force Over Mass Capital (https://capitalatlas.ai/funds/force-over-mass-capital) — Series A